On 8-hydroxyquinoline-zinc oxide incompatibility.
D000328:Adult; D000368:Aged; D002176:Candida albicans / Q000187:drug effects; D002750:Chlorquinaldol / Q000009:adverse effects / Q000494:pharmacology; D003864:Depression, Chemical; D003877:Dermatitis, Contact / Q000209:etiology*; D004336:Drug Antagonism; D004342:Drug Hypersensitivity; D004485:Eczema / Q000139:chemically induced*; D004821:Epidermophyton / Q000187:drug effects; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D013213:Starch / Q000494:pharmacology; D013268:Stimulation, Chemical; D014025:Titanium / Q000494:pharmacology; D014249:Trichophyton / Q000187:drug effects; D015032:Zinc / Q000009:adverse effects*; D015034:Zinc Oxide / Q000009:adverse effects* / Q000494:pharmacology
D006912:Hydroxyquinolines; D013213:Starch; D014025:Titanium; D002750:Chlorquinaldol; D015032:Zinc; D015034:Zinc Oxide